YIH
ATOS icon

Y-Intercept (HK)’s Atossa Therapeutics ATOS Stock Holding History

Y-Intercept (HK)’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,756
Closed -$321K – 1562
2025
Q2 		$321K Buy
+25,756
New +$308K 0.01% 1341
2024
Q2 		– Sell
-7,623
Closed -$206K – 1380
2024
Q1 		$206K Buy
+7,623
New +$122K 0.02% 1144
2022
Q3 		– Sell
-1,127
Closed -$18K – 956
2022
Q2 		$18K Buy
+1,127
New +$17.8K ﹤0.01% 792

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Y-Intercept (HK)'s ATOS Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Atossa Therapeutics (ATOS) in Q3 2025, closing a stake of 25,756 shares — an estimated $321K sold.

Y-Intercept (HK) first reported a position in ATOS in Q2 2022 and held it in 3 quarters. The position peaked at $321K in Q2 2025. 66 funds tracked by Wall St. Rank hold ATOS as of Q3 2025.

  • Y-Intercept (HK) reported no remaining Atossa Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 25,756 Atossa Therapeutics shares in Q3 2025, an estimated $321K.
  • Y-Intercept (HK) first reported a position in Atossa Therapeutics in Q2 2022 and held it in 3 quarters.
  • Y-Intercept (HK)'s Atossa Therapeutics position peaked at $321K in Q2 2025.
  • 66 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.